查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587498

干细胞市场规模、份额、趋势分析报告：2025-2030 年按产品、应用、技术、疗法、最终用途、地区和细分市场进行的预测

Stem Cells Market Size, Share & Trends Analysis Report By Product (Adult Stem Cells, Human Embryonic Stem Cells), By Application (Regenerative Medicine), By Technology, Therapy, End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

干细胞市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球干细胞市场规模将达到288.9亿美元，2025年至2030年复合年增长率为11.41%。

干细胞是可以分化成各种其他细胞并最终形成器官和组织的细胞。多年来，人们进行了​​大量研究来评估干细胞的真正潜力，从而在遗传疾病治疗、神经系统疾病、肿瘤学和器官再生等领域中广泛应用。推动这一市场发展的是银行数量的增加、对增强这些产品的治疗潜力的日益关注以及对再生医学开发的广泛研究。

对再生疗法的日益关注是市场扩张的驱动力。 iPS 细胞在创建客製化细胞疗法方面越来越受欢迎，为再生医学开闢了新的可能性。例如，2020 年 9 月，杜克-新加坡国立大学和莫纳什大学的研究人员发现了第一个可以帮助治疗怀孕期间胎盘问题的干细胞。研究人员设计了一种新方法来製造可用于生成胎盘细胞的人工绒毛干细胞。这项研究将有助于开发体外人类胎盘模型，并为未来的治疗铺平道路。

此外，COVID-19 正在充当推动市场成长的催化剂。包括美国、中国和伊朗在内的多个国家已开始使用细胞疗法治疗 COVID-19感染疾病进行临床试验。此外，使用细胞疗法治疗 COVID-19 患者取得了优异的效果，这也推动了市场的扩张。 2020 年 1 月，中国北京的研究小组对患者进行了一项试验，看看干细胞疗法是否有助于对抗 COVID-19。这项研究发现，在治疗的初始试验期间，向 COVID-19 患者静脉注射临床级 MSC 可以改善他们的功能结果并加速康復。

癌症盛行率的增加是导致预测期内成长的主要因素之一。联合治疗和化疗在癌症治疗中的失败正在推动成长，因为医生的偏好从此类治疗转向自体和同种异体干细胞疗法。此外，主要市场相关人员和政府机构继续投资于癌症研究。例如，2021年11月，加州再生医学研究所拨款400万美元用于治疗急性淋巴性白血病（ALL）、慢性淋巴性白血病（CLL）和套细胞淋巴瘤（MCL）患者。

使用和采用基于细胞的疗法的新技术的引入预计将在预测期内推动成长。成体干细胞和脐带血处理和储存的自动化是预计将对市场成长产生积极影响的关键技术。例如，许多科学家都致力于核准使用干细胞治疗多种疾病的安全且成功的疗法。 2021年，Biotech Cellino等公司投资了7,500万美元，致力于融合人工智慧技术，开发自动化干细胞製造。

另一方面，高昂的处理成本预计将阻碍市场成长。例如，干细胞研究公司 Bioinformant 报告称，每位患者的干细胞治疗费用在 5,000 美元到 8,000 美元之间，有些病例的费用超过 25,000 美元，具体取决于手术的复杂程度。此外，对干细胞研究活动的监管传统上阻碍了胚胎干细胞的生长，导致儘管有好处，但其在整个市场中所占的份额很小。

干细胞市场报告亮点

  • 成体干细胞在2024年占据市场最大的销售份额，为70.76%，因为它们不像胚胎干细胞那样涉及胚胎的破坏。
  • 由于政府对再生医学开发的资助增加，再生医学在 2024 年占据市场主导地位。
  • 2024年，电池收购领域的收益占有率最高，为33.43%。胚胎干细胞的发现为开发多种疾病的新疗法铺平了道路。
  • 2024年，同种疗法领域的收益占有率最高，达59.33%。
  • 2024 年，製药和生技公司细分市场的收益占有率最大，为 54.19%。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制与挑战分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章 产品经营分析

  • 干细胞市场：产品波动分析
  • 成体干细胞（ASC）
    • 成体干细胞 (ASC) 市场，2018-2030
    • 造血作用
    • 间质
    • 神经的
    • 上皮/皮肤
    • 其他的
  • 人类胚胎干细胞（HESC）
    • 人类胚胎干细胞（HESC）市场，2018-2030
  • 诱导性多功能干细胞(iPSC)
    • 诱导性多功能干细胞(iPSC) 市场，2018-2030
  • 微小胚胎干细胞
    • 最小胚胎干细胞市场，2018-2030

第五章 应用业务分析

  • 干细胞市场：应用变化分析
  • 再生医学
    • 再生医学市场，2018-2030
    • 神经病学
    • 整形外科
    • 肿瘤学
    • 血液学
    • 心血管疾病和心肌梗塞
    • 受伤
    • 糖尿病
    • 肝臟疾病
    • 失禁
    • 其他的
  • 药物发现与开发
    • 药物发现与开发市场，2018-2030

第六章技术业务分析

  • 干细胞市场：技术波动分析
  • 细胞采集
    • 2018-2030 年细胞采集市场
    • 骨髓采集
    • 脐带血
    • 血浆分离术
  • 细胞生产
    • 2018-2030年电池片生产市场
    • 用于治疗目的的克隆
    • 体外受精
    • 细胞培养
    • 分离
  • 冷冻保存
    • 冷冻保存市场，2018-2030
  • 扩张/继代培养
    • 扩张和继代培养市场，2018-2030

第七章治疗业务分析

  • 干细胞市场：治疗变异分析
  • 自体移植
    • 自体移植市场，2018-2030
  • 同种异体的
    • 同种异体市场，2018-2030

第八章 应用业务分析

  • 干细胞市场：应用变化分析
  • 感染疾病
    • 感染疾病市场，2018-2030
  • 免疫学
    • 免疫学市场，2018-2030
  • 肿瘤学
    • 肿瘤市场，2018-2030
  • 干细胞
    • 干细胞市场，2018-2030
  • 神经生物学
    • 神经生物学市场，2018-2030
  • 其他的
    • 其他应用市场，2018-2030

第 9 章最终用途业务分析

  • 干细胞市场：最终用途变化分析
  • 製药和生物技术公司
    • 製药和生物技术公司市场，2018-2030
  • 医院和细胞库
    • 医院和细胞库市场，2018-2030
  • 学术研究所
    • 学术研究机构市场，2018-2030

第10章区域业务分析

  • 2025 年及 2030 年干细胞市场占有率（按地区）
  • 北美洲
    • 北美干细胞市场，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲干细胞市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太干细胞市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲干细胞市场，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 中东和非洲干细胞市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十一章竞争格局

  • 公司分类
  • 策略规划
  • 2024 年企业市场分析
  • 公司简介/上市公司
    • Thermo Fisher Scientific, Inc.
    • STEMCELL Technologies Inc.
    • Merck KGaA
    • CellGenix GmbH
    • PromoCell GmbH
    • Takara Holdings, Inc.
    • Lonza
    • Cellular Engineering Technologies
    • ATCC
    • AcceGen
    • Cell Applications, Inc.
    • Bio-Techne
Product Code: 978-1-68038-130-6

Stem Cells Market Growth & Trends:

The global stem cells market size is expected to reach USD 28.89 billion by 2030, registering a CAGR of 11.41% from 2025 to 2030, according to a new report by Grand View Research, Inc. Stem cells are cells that can differentiate into a variety of other cells, eventually forming organs or tissues. Many studies have been conducted over the years to assess the true potential of stem cells, leading to a variety of applications in the fields of genetic disease treatment, neurological disorders, oncology, and organ regeneration. The market is driven by the rising number of banks, growing focus on increasing therapeutic potential of these products, and extensive research for the development of regenerative medicines, among other factors.

The growing focus on regenerative therapies is fueling market expansion. iPSCs are becoming increasingly popular for the creation of customized cellular therapies, and opening up new possibilities in regenerative medicine. For instance, in September 2020, researchers from Duke-NUS and Monash University discovered the first stem cell that can aid in the treatment of placenta issues during pregnancy. The researchers devised a new method for producing induced trophoblast stem cells that can be used to generate placenta cells. The research will aid in the development of an in-vitro human placenta model and pave the way for future therapies.

Moreover, COVID-19 is acting as a catalyst for promoting the market growth. Several countries such as U.S., China, and Iran, have started conducting clinical trials using cellular therapies for treatment of COVID-19 infections. Furthermore, the use of cell therapy in the treatment of COVID-19 patients has yielded excellent results, which is fueling market expansion. In January 2020, a group of researchers in Beijing, China, tested stem cell treatment on patients to see if it was beneficial against COVID-19. The study found that administering intravenous clinical-grade MSCs to COVID-19 patients during first trial of treatment, improved their functional results and promoted enhanced recovery.

Increasing prevalence of cancer is one of the key factors contributing to the growth over the forecast period. Failure of combination therapy and chemotherapy for treatment of cancer has led to the shift in preference of physicians from such therapies to autologous and allogeneic stem cell therapy, thereby boosting the growth. Moreover, key market players and the government bodies are continuously investing in cancer research. For instance, in November 2021, California Institute for Regenerative Medicine invested USD 4 million in therapy targeting patients with acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)

Introduction of novel technologies for the usage and adoption of cell based therapy is expected to boost the growth over the forecast period. Automation in adult stem cell & cord blood processing and storage are the key technologies expected to positively influence the market growth. For instance, various scientists are aiming for the approval of safe, and successful treatments using stem cells in a broad range of diseases. In 2021, companies such as Biotech Cellino invested USD 75 million in an effort to merge Artificial Intelligence technology for the development of automated stem cell manufacturing, that has the ability to regularizing access to cell treatments while aiming to be cost effective.

On the other hand, high cost of therapy is expected to hinder the market growth. For example, Bio informant, a stem cell research firm, reported that the cost of stem cell therapy ranges between USD 5,000 and USD 8,000 per patient, with some cases costing as much as USD 25,000 or more depending on the complexity of the procedure. Furthermore, restrictions on stem cell research activities have traditionally hampered embryonic stem cell growth, resulting in a meager share of the total market despite its advantages.

Stem Cells Market Report Highlights:

  • Adult stem cells held the largest revenue share of 70.76% of the market in 2024 as these cells do not involve the destruction of embryos, which is the case in embryonic stem cells
  • Regenerative medicine dominated the market in 2024 owing to increasing funding by the government for the development of regenerative medicines
  • The cell acquisition segment captured the highest revenue share of 33.43% of the market in 2024. The discovery of embryonic stem cells has paved the way for the development of novel treatments for several diseases
  • The allogenic therapy segment captured the largest revenue share of 59.33% in 2024 with regard to revenue generation
  • The pharmaceutical and biotechnology companies segment captured the largest revenue share of 54.19% in 2024

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product Segment
    • 1.1.2. Application Segment
    • 1.1.3. Technology Segment
    • 1.1.4. Therapy Segment
    • 1.1.5. End-use Segment
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List Of Secondary Sources
  • 1.8. List Of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Ongoing Developments In Regenerative Medicine
      • 3.2.1.2. Rising Funds For Accelerating Stem Cell Research
      • 3.2.1.3. Growing Demand For Stem Cell Banking
      • 3.2.1.4. Increasing Prevalence Of Genetic Disorders and Cancer
    • 3.2.2. Market Restraint And Challenges Analysis
      • 3.2.2.1. Ethical Concern Related To Stem Cell Research
      • 3.2.2.2. Lack Of A Well-Defined Regulatory Framework In Certain Applications Of Stem Cell
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Stem Cells Market: Product Movement Analysis
  • 4.2. Adult Stem Cells (ASCs)
    • 4.2.1. Adult Stem Cells (ASCs) Market, 2018 - 2030 (USD Billion)
    • 4.2.2. Hematopoietic
      • 4.2.2.1. Hematopoietic Market, 2018 - 2030 (USD Billion)
    • 4.2.3. Mesenchymal
      • 4.2.3.1. Mesenchymal Market, 2018 - 2030 (USD Billion)
    • 4.2.4. Neural
      • 4.2.4.1. Neural Market, 2018 - 2030 (USD Billion)
    • 4.2.5. Epithelial/Skin
      • 4.2.5.1. Epithelial/Skin Market, 2018 - 2030 (USD Billion)
    • 4.2.6. Others
      • 4.2.6.1. Others Market, 2018 - 2030 (USD Billion)
  • 4.3. Human Embryonic Stem Cells (HESCs)
    • 4.3.1. Human Embryonic Stem Cells (HESCs) Market, 2018 - 2030 (USD Billion)
  • 4.4. Induced Pluripotent Stem Cells (iPSCs)
    • 4.4.1. Induced Pluripotent Stem Cells (iPSCs) Market, 2018 - 2030 (USD Billion)
  • 4.5. Very Small Embryonic Like Stem Cells
    • 4.5.1. Very Small Embryonic Like Stem Cells Market, 2018 - 2030 (USD Billion)

Chapter 5. Application Business Analysis

  • 5.1. Stem Cells Market: Application Movement Analysis
  • 5.2. Regenerative Medicine
    • 5.2.1. Regenerative Medicine Market, 2018 - 2030 (USD Billion)
    • 5.2.2. Neurology
      • 5.2.2.1. Neurology Market, 2018 - 2030 (USD Billion)
    • 5.2.3. Orthopedics
      • 5.2.3.1. Orthopedics Market, 2018 - 2030 (USD Billion)
    • 5.2.4. Oncology
      • 5.2.4.1. Oncology Market, 2018 - 2030 (USD Billion)
    • 5.2.5. Hematology
      • 5.2.5.1. Hematology Market, 2018 - 2030 (USD Billion)
    • 5.2.6. Cardiovascular and Myocardial Infraction
      • 5.2.6.1. Cardiovascular and Myocardial Infraction Market, 2018 - 2030 (USD Billion)
    • 5.2.7. Injuries
      • 5.2.7.1. Injuries Market, 2018 - 2030 (USD Billion)
    • 5.2.8. Diabetes
      • 5.2.8.1. Diabetes Market, 2018 - 2030 (USD Billion)
    • 5.2.9. Liver Disorder
      • 5.2.9.1. Liver Disorder Market, 2018 - 2030 (USD Billion)
    • 5.2.10. Incontinence
      • 5.2.10.1. Incontinence Market, 2018 - 2030 (USD Billion)
    • 5.2.11. Others
      • 5.2.11.1. Others Market, 2018 - 2030 (USD Billion)
  • 5.3. Drug Discovery and Development
    • 5.3.1. Drug Discovery and Development Market, 2018 - 2030 (USD Billion)

Chapter 6. Technology Business Analysis

  • 6.1. Stem Cells Market: Technology Movement Analysis
  • 6.2. Cell Acquisition
    • 6.2.1. Cell Acquisition Market, 2018 - 2030 (USD Billion)
    • 6.2.2. Bone Marrow Harvest
      • 6.2.2.1. Bone Marrow Harvest Market, 2018 - 2030 (USD Billion)
    • 6.2.3. Umbilical Blood Cord
      • 6.2.3.1. Umbilical Blood Cord Market, 2018 - 2030 (USD Billion)
    • 6.2.4. Apheresis
      • 6.2.4.1. Apheresis Market, 2018 - 2030 (USD Billion)
  • 6.3. Cell Production
    • 6.3.1. Cell Production Market, 2018 - 2030 (USD Billion)
    • 6.3.2. Therapeutic Cloning
      • 6.3.2.1. Therapeutic Cloning Market, 2018 - 2030 (USD Billion)
    • 6.3.3. In-vitro Fertilization
      • 6.3.3.1. In-vitro Fertilization Market, 2018 - 2030 (USD Billion)
    • 6.3.4. Cell Culture
      • 6.3.4.1. Cell Culture Market, 2018 - 2030 (USD Billion)
    • 6.3.5. Isolation
      • 6.3.5.1. Isolation Market, 2018 - 2030 (USD Billion)
  • 6.4. Cryopreservation
    • 6.4.1. Cryopreservation Market, 2018 - 2030 (USD Billion)
  • 6.5. Expansion and Sub-Culture
    • 6.5.1. Expansion and Sub-Culture Market, 2018 - 2030 (USD Billion)

Chapter 7. Therapy Business Analysis

  • 7.1. Stem Cells Market: Therapy Movement Analysis
  • 7.2. Autologous
    • 7.2.1. Autologous Market, 2018 - 2030 (USD Billion)
  • 7.3. Allogeneic
    • 7.3.1. Allogeneic Market, 2018 - 2030 (USD Billion)

Chapter 8. Application Business Analysis

  • 8.1. Stem Cells Market: Application Movement Analysis
  • 8.2. Infectious Diseases
    • 8.2.1. Infectious Diseases Market, 2018 - 2030 (USD Billion)
  • 8.3. Immunology
    • 8.3.1. Immunology Market, 2018 - 2030 (USD Billion)
  • 8.4. Oncology
    • 8.4.1. Oncology Market, 2018 - 2030 (USD Billion)
  • 8.5. Stem Cells
    • 8.5.1. Stem Cells Market, 2018 - 2030 (USD Billion)
  • 8.6. Neurobiology
    • 8.6.1. Neurobiology Market, 2018 - 2030 (USD Billion)
  • 8.7. Others
    • 8.7.1. Other Applications Market, 2018 - 2030 (USD Billion)

Chapter 9. End Use Business Analysis

  • 9.1. Stem Cells Market: End-use Movement Analysis
  • 9.2. Pharmaceutical and Biotechnology Companies
    • 9.2.1. Pharmaceutical and Biotechnology Companies Market, 2018 - 2030 (USD Billion)
  • 9.3. Hospitals & Cell Banks
    • 9.3.1. Hospitals & Cell Banks Market, 2018 - 2030 (USD Billion)
  • 9.4. Academic & Research Institutes
    • 9.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Billion)

Chapter 10. Regional Business Analysis

  • 10.1. Stem Cells Market Share By Region, 2025 & 2030
  • 10.2. North America
    • 10.2.1. North America Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.2.2. U.S.
      • 10.2.2.1. Key Country Dynamics
      • 10.2.2.2. Target Disease Prevalence
      • 10.2.2.3. Competitive Scenario
      • 10.2.2.4. Regulatory Framework
      • 10.2.2.5. U.S. Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.2.3. Canada
      • 10.2.3.1. Key Country Dynamics
      • 10.2.3.2. Target Disease Prevalence
      • 10.2.3.3. Competitive Scenario
      • 10.2.3.4. Regulatory Framework
      • 10.2.3.5. Canada Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.2.4. Mexico
      • 10.2.4.1. Key Country Dynamics
      • 10.2.4.2. Target Disease Prevalence
      • 10.2.4.3. Competitive Scenario
      • 10.2.4.4. Regulatory Framework
      • 10.2.4.5. Mexico Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.3. Europe
    • 10.3.1. Europe Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.2. UK
      • 10.3.2.1. Key Country Dynamics
      • 10.3.2.2. Target Disease Prevalence
      • 10.3.2.3. Competitive Scenario
      • 10.3.2.4. Regulatory Framework
      • 10.3.2.5. UK Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.3. Germany
      • 10.3.3.1. Key Country Dynamics
      • 10.3.3.2. Target Disease Prevalence
      • 10.3.3.3. Competitive Scenario
      • 10.3.3.4. Regulatory Framework
      • 10.3.3.5. Germany Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.4. France
      • 10.3.4.1. Key Country Dynamics
      • 10.3.4.2. Target Disease Prevalence
      • 10.3.4.3. Competitive Scenario
      • 10.3.4.4. Regulatory Framework
      • 10.3.4.5. France Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.5. Italy
      • 10.3.5.1. Key Country Dynamics
      • 10.3.5.2. Target Disease Prevalence
      • 10.3.5.3. Competitive Scenario
      • 10.3.5.4. Regulatory Framework
      • 10.3.5.5. Italy Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.6. Spain
      • 10.3.6.1. Key Country Dynamics
      • 10.3.6.2. Target Disease Prevalence
      • 10.3.6.3. Competitive Scenario
      • 10.3.6.4. Regulatory Framework
      • 10.3.6.5. Spain Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.7. Denmark
      • 10.3.7.1. Key Country Dynamics
      • 10.3.7.2. Target Disease Prevalence
      • 10.3.7.3. Competitive Scenario
      • 10.3.7.4. Regulatory Framework
      • 10.3.7.5. Denmark Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.8. Sweden
      • 10.3.8.1. Key Country Dynamics
      • 10.3.8.2. Target Disease Prevalence
      • 10.3.8.3. Competitive Scenario
      • 10.3.8.4. Regulatory Framework
      • 10.3.8.5. Sweden Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.9. Norway
      • 10.3.9.1. Key Country Dynamics
      • 10.3.9.2. Target Disease Prevalence
      • 10.3.9.3. Competitive Scenario
      • 10.3.9.4. Regulatory Framework
      • 10.3.9.5. Norway Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.4. Asia Pacific
    • 10.4.1. Asia Pacific Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.4.2. Japan
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Target Disease Prevalence
      • 10.4.2.3. Competitive Scenario
      • 10.4.2.4. Regulatory Framework
      • 10.4.2.5. Japan Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.4.3. China
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Target Disease Prevalence
      • 10.4.3.3. Competitive Scenario
      • 10.4.3.4. Regulatory Framework
      • 10.4.3.5. China Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.4.4. India
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Target Disease Prevalence
      • 10.4.4.3. Competitive Scenario
      • 10.4.4.4. Regulatory Framework
      • 10.4.4.5. India Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.4.5. Australia
      • 10.4.5.1. Key Country Dynamics
      • 10.4.5.2. Target Disease Prevalence
      • 10.4.5.3. Competitive Scenario
      • 10.4.5.4. Regulatory Framework
      • 10.4.5.5. Australia Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.4.6. Thailand
      • 10.4.6.1. Key Country Dynamics
      • 10.4.6.2. Target Disease Prevalence
      • 10.4.6.3. Competitive Scenario
      • 10.4.6.4. Regulatory Framework
      • 10.4.6.5. Thailand Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.4.7. South Korea
      • 10.4.7.1. Key Country Dynamics
      • 10.4.7.2. Target Disease Prevalence
      • 10.4.7.3. Competitive Scenario
      • 10.4.7.4. Regulatory Framework
      • 10.4.7.5. South Korea Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.5. Latin America
    • 10.5.1. Latin America Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.5.2. Brazil
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Target Disease Prevalence
      • 10.5.2.3. Competitive Scenario
      • 10.5.2.4. Regulatory Framework
      • 10.5.2.5. Brazil Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.5.3. Argentina
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Target Disease Prevalence
      • 10.5.3.3. Competitive Scenario
      • 10.5.3.4. Regulatory Framework
      • 10.5.3.5. Argentina Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.6. MEA
    • 10.6.1. MEA Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.6.2. South Africa
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Target Disease Prevalence
      • 10.6.2.3. Competitive Scenario
      • 10.6.2.4. Regulatory Framework
      • 10.6.2.5. South Africa Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.6.3. Saudi Arabia
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Target Disease Prevalence
      • 10.6.3.3. Competitive Scenario
      • 10.6.3.4. Regulatory Framework
      • 10.6.3.5. Saudi Arabia Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.6.4. UAE
      • 10.6.4.1. Key Country Dynamics
      • 10.6.4.2. Target Disease Prevalence
      • 10.6.4.3. Competitive Scenario
      • 10.6.4.4. Regulatory Framework
      • 10.6.4.5. UAE Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.6.5. Kuwait
      • 10.6.5.1. Key Country Dynamics
      • 10.6.5.2. Target Disease Prevalence
      • 10.6.5.3. Competitive Scenario
      • 10.6.5.4. Regulatory Framework
      • 10.6.5.5. Kuwait Stem Cells Market, 2018 - 2030 (USD Billion)

Chapter 11. Competitive Landscape

  • 11.1. Company Categorization
  • 11.2. Strategy Mapping
  • 11.3. Company Market Position Analysis, 2024
  • 11.4. Company Profiles/Listing
    • 11.4.1. Thermo Fisher Scientific, Inc.
      • 11.4.1.1. Overview
      • 11.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.1.3. Product Benchmarking
      • 11.4.1.4. Strategic Initiatives
    • 11.4.2. STEMCELL Technologies Inc.
      • 11.4.2.1. Overview
      • 11.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.2.3. Product Benchmarking
      • 11.4.2.4. Strategic Initiatives
    • 11.4.3. Merck KGaA
      • 11.4.3.1. Overview
      • 11.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.3.3. Product Benchmarking
      • 11.4.3.4. Strategic Initiatives
    • 11.4.4. CellGenix GmbH
      • 11.4.4.1. Overview
      • 11.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.4.3. Product Benchmarking
      • 11.4.4.4. Strategic Initiatives
    • 11.4.5. PromoCell GmbH
      • 11.4.5.1. Overview
      • 11.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.5.3. Product Benchmarking
      • 11.4.5.4. Strategic Initiatives
    • 11.4.6. Takara Holdings, Inc.
      • 11.4.6.1. Overview
      • 11.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.6.3. Product Benchmarking
      • 11.4.6.4. Strategic Initiatives
    • 11.4.7. Lonza
      • 11.4.7.1. Overview
      • 11.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.7.3. Product Benchmarking
      • 11.4.7.4. Strategic Initiatives
    • 11.4.8. Cellular Engineering Technologies
      • 11.4.8.1. Overview
      • 11.4.8.2. Product Benchmarking
      • 11.4.8.3. Strategic Initiatives
    • 11.4.9. ATCC
      • 11.4.9.1. Overview
      • 11.4.9.2. Product Benchmarking
      • 11.4.9.3. Strategic Initiatives
    • 11.4.10. AcceGen
      • 11.4.10.1. Overview
      • 11.4.10.2. Product Benchmarking
      • 11.4.10.3. Strategic Initiatives
    • 11.4.11. Cell Applications, Inc.
      • 11.4.11.1. Overview
      • 11.4.11.2. Product Benchmarking
      • 11.4.11.3. Strategic Initiatives
    • 11.4.12. Bio-Techne
      • 11.4.12.1. Overview
      • 11.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.12.3. Product Benchmarking
      • 11.4.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Global Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 4 Global Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 5 Global Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 6 Global Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 7 Global Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 8 Global Stem Cells Market, by Region, 2018 - 2030 (USD Million)
  • TABLE 9 North America Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 10 North America Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 11 North America Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 12 North America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 13 North America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 14 North America Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 15 U.S. Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 16 U.S. Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 17 U.S. Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 18 U.S. Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 19 U.S. Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 20 Mexico Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 21 Mexico Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 22 Mexico Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 23 Mexico Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 24 Mexico Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 25 Canada Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 26 Canada Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 27 Canada Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 28 Canada Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 29 Canada Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 30 Europe Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 31 Europe Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 32 Europe Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 33 Europe Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 34 Europe Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 35 Europe Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 36 Germany Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 37 Germany Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 38 Germany Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 39 Germany Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 40 Germany Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 41 UK Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 42 UK Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 43 UK Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 44 UK Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 45 UK Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 46 France Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 47 France Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 48 France Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 49 France Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 50 France Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 51 Italy Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 52 Italy Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 53 Italy Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 54 Italy Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 55 Italy Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 56 Spain Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 57 Spain Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 58 Spain Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 59 Spain Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 60 Spain Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 61 Denmark Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 62 Denmark Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 63 Denmark Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 64 Denmark Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 65 Denmark Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 66 Sweden Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 67 Sweden Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 68 Sweden Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 69 Sweden Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 70 Sweden Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 71 Norway Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 72 Norway Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 73 Norway Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 74 Norway Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 75 Norway Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 76 Asia Pacific Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 77 Asia Pacific Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 78 Asia Pacific Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 79 Asia Pacific Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 80 Asia Pacific Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 81 Asia Pacific Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 82 China Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 83 China Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 84 China Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 85 China Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 86 China Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 87 Japan Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 88 Japan Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 89 Japan Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 90 Japan Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 91 Japan Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 92 India Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 93 India Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 94 India Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 95 India Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 96 India Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 97 South Korea Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 98 South Korea Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 99 South Korea Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 100 South Korea Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 101 South Korea Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 102 Australia Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 103 Australia Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 104 Australia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 105 Australia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 106 Australia Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 107 Thailand Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 108 Thailand Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 109 Thailand Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 110 Thailand Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 111 Thailand Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 112 Latin America Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 113 Latin America Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 114 Latin America Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 115 Latin America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 116 Latin America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 117 Latin America Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 118 Brazil Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 119 Brazil Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 120 Brazil Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 121 Brazil Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 122 Brazil Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 123 Argentina Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 124 Argentina Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 125 Argentina Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 126 Argentina Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 127 Argentina Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 128 Middle East & Africa Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 129 Middle East & Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 130 Middle East & Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 131 Middle East & Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 132 Middle East & Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 133 Middle East & Africa Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 134 South Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 135 South Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 136 South Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 137 South Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 138 South Africa Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 139 Saudi Arabia Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 140 Saudi Arabia Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 141 Saudi Arabia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 142 Saudi Arabia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 143 Saudi Arabia Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 144 UAE Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 145 UAE Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 146 UAE Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 147 UAE Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 148 UAE Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 149 Kuwait Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 150 Kuwait Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 151 Kuwait Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 152 Kuwait Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 153 Kuwait Stem Cells Market, by End use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Stem Cells Market Segmentation
  • FIG. 8 Market Snapshot, 2024
  • FIG. 9 Market Trends & Outlook
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 PESTEL Analysis
  • FIG. 13 Porter's Five Forces Analysis
  • FIG. 14 Global Stem Cells Market: Product Movement Analysis
  • FIG. 15 Global Stem Cells Market, for Adult Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 16 Global Stem Cells Market, for Hematopoietic Stem Cells (Blood Stem Cells), 2018 - 2030 (USD Million)
  • FIG. 17 Global Stem Cells Market, for Mesenchymal Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 18 Global Stem Cells Market, for Neural Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 19 Global Stem Cells Market, for Epithelial/Skin Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 20 Global Stem Cells Market, for Other Adult Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 21 Global Stem Cells Market, for Human Embryonic Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 22 Global Stem Cells Market, for Induced Pluripotent Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 23 Global Stem Cells Market, for Very Small Embryonic Like Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 24 Global Stem Cells Market: Application Movement Analysis
  • FIG. 25 Global Stem Cells Market, for Regenerative Medicine, 2018 - 2030 (USD Million)
  • FIG. 26 Global Stem Cells Market, for Neurology, 2018 - 2030 (USD Million)
  • FIG. 27 Global Stem Cells Market, for Orthopedics, 2018 - 2030 (USD Million)
  • FIG. 28 Global Stem Cells Market, for Oncology, 2018 - 2030 (USD Million)
  • FIG. 29 Global Stem Cells Market, for Hematology, 2018 - 2030 (USD Million)
  • FIG. 30 Global Stem Cells Market, for Cardiovascular and Myocardial Infraction, 2018 - 2030 (USD Million)
  • FIG. 31 Global Stem Cells Market, for Injuries, 2018 - 2030 (USD Million)
  • FIG. 32 Global Stem Cells Market, for Diabetes, 2018 - 2030 (USD Million)
  • FIG. 33 Global Stem Cells Market, for Liver Disorder, 2018 - 2030 (USD Million)
  • FIG. 34 Global Stem Cells Market, for Incontinence, 2018 - 2030 (USD Million)
  • FIG. 35 Global Stem Cells Market, for Others, 2018 - 2030 (USD Million)
  • FIG. 36 Global Stem Cells Market, for Drug Discovery and Development, 2018 - 2030 (USD Million)
  • FIG. 37 Global Stem Cells Market: Technology Movement Analysis
  • FIG. 38 Global Stem Cells Market, for Cell Acquisition, 2018 - 2030 (USD Million)
  • FIG. 39 Global Stem Cells Market, for Bone Marrow Harvest, 2018 - 2030 (USD Million)
  • FIG. 40 Global Stem Cells Market, for Umbilical Blood Cord, 2018 - 2030 (USD Million)
  • FIG. 41 Global Stem Cells Market, for Apheresis, 2018 - 2030 (USD Million)
  • FIG. 42 Global Stem Cells Market, for Cell Production, 2018 - 2030 (USD Million)
  • FIG. 43 Global Stem Cells Market, for Therapeutic Cloning, 2018 - 2030 (USD Million)
  • FIG. 44 Global Stem Cells Market, for In Vitro Fertilization, 2018 - 2030 (USD Million)
  • FIG. 45 Global Stem Cells Market, for Cell Culture, 2018 - 2030 (USD Million)
  • FIG. 46 Global Stem Cells Market, for Isolation, 2018 - 2030 (USD Million)
  • FIG. 47 Global Stem Cells Market, for Cryopreservation, 2018 - 2030 (USD Million)
  • FIG. 48 Global Stem Cells Market, for Expansion and Sub-Culture, 2018 - 2030 (USD Million)
  • FIG. 49 Global Stem Cells Market: Therapy Movement Analysis
  • FIG. 50 Global Stem Cells Market, for Autologous, 2018 - 2030 (USD Million)
  • FIG. 51 Global Stem Cells Market, for Allogeneic, 2018 - 2030 (USD Million)
  • FIG. 52 Global Stem Cells Market, End-User Movement Analysis
  • FIG. 53 Global Stem Cells Market, for Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)
  • FIG. 54 Global Stem Cells Market, for Hospitals & Cell Banks, 2018 - 2030 (USD Million)
  • FIG. 55 Global Stem Cells Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • FIG. 56 Regional Outlook, 2024 & 2030
  • FIG. 57 Global Stem Cells Market: Region Movement Analysis
  • FIG. 58 North America Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 59 U.S. Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 60 Canada Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 61 Europe Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 62 Germany Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 63 UK Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 64 France Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 65 Italy Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 66 Spain Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 67 Denmark Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 68 Norway Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 69 Sweden Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 70 Asia Pacific Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 71 Japan Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 72 China Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 73 India Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 74 Australia Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 75 South Korea Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 76 Thailand Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 77 Latin America Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 78 Brazil Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 79 Mexico Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 80 Argentina Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 81 Middle East and Africa Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 82 South Africa Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 83 Saudi Arabia Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 84 UAE Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 85 Kuwait Stem Cells Market, 2018 - 2030 (USD Million)